Home » Posts tagged with » Johnson & Johnson (Page 2)
Janssen Pharmaceutical has bagged approval from the US Food and Drug Administration (FDA) for its combo of IMBRUVICA (ibrutinib) and rituximab for the treatment of Waldenström’s macroglobulinemia (WM), a rare blood cancer. The FDA approval secured by the Johnson & Johnson subsidiary expands IMBRUVICA’s current label in Waldenström’s macroglobulinemia as a monotherapy to include its […]
Continue reading …
Business News Today
- Rio Grande LNG export project : NextDecade gets DOE’s non-FTA export authorization
- Catalent Pharma Solutions acquires cell and gene therapy CDMO MaSTherCell
- Duravant to acquire electronic fruit and vegetable sorters manufacturer WECO
- McNeil & Company acquires LOSAP administrator Penflex
- DXP Enterprises acquires pump repair company Turbo Machinery Repair
- Eco-Energy nears completion on ethanol distribution terminal in Phoenix
- KNOT wins contract for two LNG-fueled shuttle tankers from Eni
- Olympus secures FDA clearance for TJF-Q190V duodenoscope
- CytoSorbents gets CytoSorb EU approval for removal of ticagrelor during CPB
- Novel Coronavirus : Novaerus portable air disinfection units to be used in Chinese healthcare facilities
